Windsor, Alberta 1/26/2010 12:50:00 AM
News / Business

Helix BioPharma Will be Providing a Presentation at the Bio Asia International Partnering Conference

Helix BioPharma Corp. (TSX: HBP) (Pink Sheets: HXBPF) will present at the BIO Asia 7th Annual International Partnering Conference. The event is being held in Tokyo, Japan at the Grand Hyatt Tokyo. The company has been scheduled to host their presentation on January 26th at 1:00pm (JST).

 

Free Hot Penny Stocks, an online financial publication, provides investors timely stock market alerts. Free hot penny stocks profiles stock picks that could generate higher returns than average. These penny stocks include stocks with news, chart breakouts or increased volume.

 

Sign Up Today for our Penny Stock Newsletter

 

The company's Chief Scientific Officer, Heman Chao, will present an overview on their leading product development programs L-DOS47 and Topical Interferon Alpha-2b

 

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy.  The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies.

 

Sign Up for Free Hot Penny Stocks’ FREE Penny Stock Newsletter.

 

About Us

 

Free Hot Penny Stocks is a financial website and independent electronic publication that provides information and free penny stock alerts on selected publicly traded companies. We also track small cap companies and other stocks that may be positioned to break out. These penny stocks might have news, increased volume or chart breakouts. These penny stocks that are alerted could generate greater than average returns. Feel free to visit our penny stock forum to discuss other penny stock picks or penny stocks that you might own.

 

Free Hot Penny Stocks is not a registered investment advisor or broker-dealer. Please do your own Due Diligence before investing in any of the stocks mentioned above. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer